The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

Ozempic is approved for the management of type 2 diabetes, but it’s also used off-label to support weight loss. The only way to get Ozempic online is through a prescription from a licensed ...

Few drugs have captured public attention like Ozempic; many of us have even taken it. The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Allowing yourself grace, patience and respect." Though Aguilera's appearance has sparked debate online about whether she has dabbled with Ozempic, the "Beautiful" singer has not directly addressed ...

What to Eat on Ozempic and What to Avoid Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this GLP-1 (glucagon-like peptide 1 ...

Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change the way America eats, food manufacturers are trying to whip themselves up a forkful of the action ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION) Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for ...

Novo Nordisk’s (NVO) blockbuster diabetes drug Ozempic may have a potential link with an eye condition that causes vision loss, according to a non-peer reviewed study published Thursday on medRxiv.